Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Farudodstat (ASLAN003) is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) with antitumor activity. It has the potential to be a first-in-class candidate in AML.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 72.00 | |
25 mg | In stock | $ 155.00 | |
50 mg | In stock | $ 255.00 | |
100 mg | In stock | $ 411.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 47.00 |
Description | Farudodstat (ASLAN003) is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) with antitumor activity. It has the potential to be a first-in-class candidate in AML. |
Targets&IC50 | DHODH enzyme (human):35 nM (IC50) |
In vitro | ASLAN003 is a highly potent dihydroorotate dehydrogenase inhibitor that induces differentiation, as well as reduces cell proliferation and viability, of acute myeloid leukemia cell lines and primary acute myeloid leukemia blasts including in chemo-resistant cells. Apoptotic pathways are triggered by ASLAN003, and it also significantly inhibits protein synthesis and activates AP-1 transcription, contributing to its differentiation promoting capacity[2]. |
In vivo | ASLAN003 substantially reduces leukemic burden and prolongs survival in acute myeloid leukemia xenograft mice and acute myeloid leukemia patient-derived xenograft models. Notably, the drug has no evident effect on normal hematopoietic cells and exhibits excellent safety profiles in mice, even after a prolonged period of administration. ASLAN003 is an agent targeting dihydroorotate dehydrogenase with potential in the treatment of acute myeloid leukemia. ASLAN003 is currently being evaluated in phase 2a clinical trial in acute myeloid leukemia patients[2]. |
Synonyms | ASLAN003 |
Molecular Weight | 356.32 |
Formula | C19H14F2N2O3 |
CAS No. | 1035688-66-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (336.78 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Farudodstat 1035688-66-4 Apoptosis Cell Cycle/Checkpoint DNA Damage/DNA Repair Metabolism Dehydrogenase DNA/RNA Synthesis AML RPL6 synthesis OPP acute protein orally EIF4B myeloid caspase-3 DHODH caspase-7 THP-1 AP-1 caspase-8 MOLM-14 ASLAN-003 inhibit ASLAN003 KG-1 leukemia Inhibitor ASLAN 003 Dihydroorotate Dehydrogenase inhibitor